Jing Peng

780 citations
24 papers · 534 indexed · h-index 11
Topics
Cancer Immunotherapy and Biomarkers (4 papers)Ovarian cancer diagnosis and treatment (4 papers)Radiomics and Machine Learning in Medical Imaging (2 papers)
Partner nations
ChinaFrance

In The Last Decade

Jing Peng

24 papers receiving 526 citations

Peers

Jing Peng
Comparison fields: 5 of 86
  • Molecular Biology 209
  • Oncology 192
  • Cancer Research 115
  • Immunology 70
  • Pulmonary and Respiratory Medicine 61
Replace Yunpeng Xie with:
Yunpeng Xie China
Sumi Dinda United States
Zhanyu Wang China
Yanyi Xiao China
Giulia Pinton Italy
Zhongqi Li China
Chunlian Wu China
Lovisa Lundholm Sweden
Jing Peng relative to Yunpeng Xie China Yunpeng Xie's profile →
Citations per field
00.5×1.5×2.1×
Yunpeng Xie · 1×
Citations per year

Countries citing papers authored by Jing Peng

Since Specialization
Citations

This map shows the geographic impact of Jing Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Peng more than expected).

Fields of papers citing papers by Jing Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Peng. The network helps show where Jing Peng may publish in the future.

Co-authorship network of co-authors of Jing Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Peng. A scholar is included among the top collaborators of Jing Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Peng. Jing Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 7
4 5
5 7
6 10
7 20
8 3
9 24
10 14
11 3
12 13
13 1
14 10
15 3
16 16
17 106
18 223
19 6
20
Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis
1

About Jing Peng

Jing Peng is a scholar working on Reproductive Medicine, Physiology and Obstetrics and Gynecology, having authored 24 papers that have together received 534 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). The work is most often cited by research in Cancer Research (115 citations), Oncology (192 citations) and Drug Discovery (1 citation). Jing Peng has collaborated with scholars based in China and France. Frequent co-authors include Timothy R. Wilson, Catherine Wilson, Jeff Settleman, Debasish Raha, Mark Merchant, Marie Evangelista, David Peterson, Yue Peng, Xiaohong Lin and Xi Xie. Their work appears in journals such as Cancer Research, Food Chemistry and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026